Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recommended Dose Estimation of BP-C2 in Patients With Prostate Cancer: A Phase I Dose-finding Study.

NCT04186585 is registered in ClinicalTrials.gov with Meddoc as lead sponsor.

NCT NCT04186585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04186585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recommended Dose Estimation of BP-C2 in Patients With Prostate Cancer: A Phase I Dose-finding Study.
Lead sponsor
Meddoc
Phase
Phase 1
Overall status
Recruiting
Start date
April 1, 2023
Completion date
September 30, 2025
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer